 Double blind, randomized, controlled, dose-escalation Phase 1 clinical trial in hookworm-exposed children aged 6 to 10 years living in the area of Lambaréné, Gabon. Children will receive three doses of the assigned vaccines delivered intramuscularly deltoid on approximately Days 0, 56, and 112 or 180. 